Breast cancer news
A new study has estimated the ages at which women with faults in two particular genes are most at risk of developing breast and ovarian cancer.
Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.
The drug trastuzumab emtansine (Kadcyla) will soon be routinely available for patients in England with an advanced type of breast cancer.
Using two immunotherapy drugs together could help treat some patients with an aggressive form of breast cancer, according to an Australian study.
The chemotherapy drug capecitabine gives patients a better quality of life and is as effective at preventing breast cancer from returning as the alternative CMF